ENTRUST-AF PCI study presented

03.09.2019

The results of the ENTRUST-AF PCI study were presented by Prof. Andreas Goette at the annual congress of the European Society of Cardiology (ESC) in Paris in the Hot Line Session 6.

ESC press release

Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G, Batushkin V, Campo G, Lysak Z, Vakaliuk I, Milewski K, Laeis P, Reimitz PE, Smolnik R, Zierhut W, Goette A. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet, 3.9.2019.

http://dx.doi.org/10.1016/S0140-6736(19)31872-0